2005
DOI: 10.1001/archinte.165.15.1756
|View full text |Cite
|
Sign up to set email alerts
|

The Burden of Staphylococcus aureus Infections on Hospitals in the United States

Abstract: Staphylococcus aureus infections represent a considerable burden to US hospitals, particularly among high-risk patient populations. The potential benefits to hospitals in terms of reduced use of resources and costs as well as improved outcomes from preventing S aureus infections are significant.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

4
85
0
2

Year Published

2007
2007
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 256 publications
(91 citation statements)
references
References 28 publications
4
85
0
2
Order By: Relevance
“…The most commonly isolated microorganism in PJI after TJA is Staphylococcus aureus [22,29]. Resistant strains such as methicillin-resistant S aureus (MRSA) are on the rise [21] and are associated with higher rates of treatment failure [3,23].…”
Section: Introductionmentioning
confidence: 99%
“…The most commonly isolated microorganism in PJI after TJA is Staphylococcus aureus [22,29]. Resistant strains such as methicillin-resistant S aureus (MRSA) are on the rise [21] and are associated with higher rates of treatment failure [3,23].…”
Section: Introductionmentioning
confidence: 99%
“…Each year in the United States, more than 300,000 patients contract S. aureus infections, leading to more than 12,000 deaths, 2.7 million excess days of hospitalization, and close to $9.5 billion in excess hospital charges (8,11). Coagulase-negative staphylococci (CoNS) are the predominant organisms isolated from positive blood cultures (7), 60 to 80% of which are the result of contamination of the sample during the blood draw due to inadequate antiseptic techniques (2,17,21).…”
mentioning
confidence: 99%
“…Several populationbased studies on S. aureus infections exist; however, these studies focused on hospital-based populations (3)(4)(5)(6), MRSA infection (7-9), non-US populations (10)(11)(12), or only estimated the impact of invasive S. aureus disease (10,(13)(14)(15). Additionally, population-level changes in incidence, particularly before and after USA300 MRSA emerged, are largely unknown.…”
mentioning
confidence: 99%